Nordea Investment Management AB Raises Position in Agilent Technologies, Inc. $A

Nordea Investment Management AB increased its position in Agilent Technologies, Inc. (NYSE:A) by 16.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,213,748 shares of the medical research company’s stock after buying an additional 447,207 shares during the quarter. Nordea Investment Management AB owned about 1.13% of Agilent Technologies worth $383,143,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Agilent Technologies by 13.5% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,674 shares of the medical research company’s stock worth $4,279,000 after buying an additional 4,362 shares during the period. Alps Advisors Inc. raised its position in shares of Agilent Technologies by 29.5% in the 1st quarter. Alps Advisors Inc. now owns 13,358 shares of the medical research company’s stock worth $1,563,000 after buying an additional 3,040 shares during the period. D.A. Davidson & CO. raised its position in shares of Agilent Technologies by 30.4% in the 1st quarter. D.A. Davidson & CO. now owns 9,474 shares of the medical research company’s stock worth $1,108,000 after buying an additional 2,207 shares during the period. LGT Capital Partners LTD. raised its position in shares of Agilent Technologies by 7.6% in the 1st quarter. LGT Capital Partners LTD. now owns 768,252 shares of the medical research company’s stock worth $89,870,000 after buying an additional 54,302 shares during the period. Finally, Live Oak Investment Partners purchased a new position in shares of Agilent Technologies in the 1st quarter worth $603,000.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on A shares. Barclays increased their target price on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 2nd. UBS Group raised Agilent Technologies from a “neutral” rating to a “buy” rating and raised their price objective for the company from $130.00 to $170.00 in a research report on Wednesday, October 8th. Rothschild Redb raised Agilent Technologies to a “strong-buy” rating in a research report on Wednesday, October 8th. Robert W. Baird raised their price objective on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a research report on Thursday, August 28th. Finally, JPMorgan Chase & Co. raised their price objective on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $149.62.

Agilent Technologies Stock Up 1.1%

Shares of Agilent Technologies stock opened at $141.14 on Friday. The business has a 50-day moving average of $127.03 and a 200-day moving average of $117.63. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The company has a market capitalization of $40.01 billion, a PE ratio of 33.13, a P/E/G ratio of 4.56 and a beta of 1.26. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting the consensus estimate of $1.37. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company’s revenue was up 10.1% on a year-over-year basis. During the same period last year, the firm earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, equities analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.